The LITAF gene helps cells sort and recycle proteins, especially in the cells that support peripheral nerves. When this process is disrupted by a pathogenic variant, the nerve covering can be affected, which may lead to slowly progressive numbness, tingling, weakness, high arches, or trouble with balance and walking. This gene plays an important role in keeping nerve signals moving smoothly from the spinal cord to the hands and feet. Pathogenic variants in the LITAF gene are linked to Charcot-Marie-Tooth disease type 1C, an inherited condition affecting peripheral nerves.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or direct processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
LITAFGene function
What if the gene works
The LITAF gene helps cells sort and recycle proteins in their recycling compartments. This supports healthy peripheral nerves, including the cells that maintain myelin, the protective covering around nerves.
Risk
What if the gene does not work
Variants in the LITAF gene are linked to Charcot-Marie-Tooth disease type 1C, which can cause slowly progressive foot and leg weakness, numbness, and high arches. Milder and more severe variants can affect when symptoms start and how noticeable they are.
Treatment
What does that mean for your treatment
No LITAF-specific treatment or drug selection approach is currently established. If you carry a pathogenic variant in the LITAF gene, care is based on your symptoms and day to day function rather than on a gene targeted medicine.
Conditions associated with LITAF
Gene function
What if the gene works
Inside your cells, the LITAF gene helps manage how proteins move through the cell’s sorting and cleanup system. Its protein sits mainly on small sacs used for sorting and breakdown, called endosomes and lysosomes. This helps explain how the LITAF gene works in cells during everyday maintenance.
The LITAF gene helps guide certain proteins from the cell surface into the cell’s internal sorting pathway. This lets cells handle incoming material in a controlled way and decide what should be reused or cleared away.
Its protein supports the route that carries worn out or extra proteins toward lysosomes, the cell’s breakdown spaces. This helps everyday cell cleanup stay organized and keeps the cell surface from becoming overcrowded.
LITAF also helps maintain the membranes of endosomes, which are compartments that move cargo inside cells. By supporting this traffic flow, it helps keep cell signaling and protein removal in balance.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some situations, however, a variant can change gene function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LITAF gene often change the shape or placement of the LITAF protein inside the cell, so it may be sent to the wrong membrane compartment and work less well in protein recycling. In LITAF gene variants, some changes are milder and leave partial activity, while others disrupt the protein more strongly or alter how it interacts with cell machinery. This range can help explain why Charcot-Marie-Tooth features may begin earlier or be more noticeable in some people.
How variants are linked to conditions
Pathogenic variants in the LITAF gene cause Charcot-Marie-Tooth disease type 1C, so discussions of the LITAF gene and Charcot-Marie-Tooth disease usually refer to this inherited nerve condition. People with this diagnosis may develop slowly progressive foot and leg weakness, numbness, high arches, or balance problems, with symptoms starting anywhere from childhood to adulthood.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences are part of the picture. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LITAF, the main driver of risk is having a disease-causing gene change, which can lead to an inherited nerve condition called Charcot-Marie-Tooth disease. Symptoms and age when problems begin can vary within families, but there is not broadly confirmed evidence that specific lifestyle or environmental factors clearly change the underlying genetic risk.
Inheritance of LITAF variants
LITAF gene variants linked to Charcot-Marie-Tooth disease type 1C are usually inherited in an autosomal dominant pattern. This means a child can inherit the condition if just one parent carries a disease-causing variant in the LITAF gene, and each pregnancy has a 50% chance of passing it on. In practical terms, LITAF gene inheritance often shows up across several generations, with an affected parent and child in the same family. Sons and daughters are affected at similar rates and can both inherit it from either parent.
What does my LITAF result mean for my family?
For LITAF, a disease-causing result is usually linked to a dominant inherited nerve condition called Charcot-Marie-Tooth disease, which means close relatives can sometimes have the same genetic change as well. Parents, brothers, sisters, and children may want to learn whether the result could apply to them, especially if they have foot weakness, balance problems, or numbness. Some family members may carry the change but have milder symptoms.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the LITAF gene, a lab can test DNA from blood, saliva, or a cheek swab. Genetic testing for LITAF variants usually reads through the gene’s DNA code and may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider testing for changes in the LITAF gene if you or close relatives have an inherited nerve condition with slowly worsening foot or hand numbness, tingling, weakness, balance problems, or very high arches. A LITAF test may help confirm a form of Charcot-Marie-Tooth disease, which affects the nerves in the arms and legs, and clarify whether it runs in the family.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person might work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to drugs in different ways. This kind of variation is common and can influence both how strongly a medicine works and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can shape their response to medications. By studying links between genes and drugs, it helps explain why the same treatment may affect people in different ways. For many medicines, genes influence how the body handles a drug and how strong its effects are. This information can support more informed, more personalized treatment decisions. More detailed information is available in the LearnHub.
Drugs influenced by the LITAF gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so questions about side effects, new symptoms, or medicine changes are best discussed with your doctor.